placebo of cilostazol

DRUG3 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd., Asan Medical Center

Conditions

Brain IschemiaCerebral InfarctionIntracranial Hemorrhages

Phase 3

Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

CompletedNCT00766545

Otsuka Pharmaceutical Co., Ltd.Cerebral Infarction

Start: 1992-04-30End: 1997-03-31Updated: 2021-03-01

Phase 4

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Asan Medical CenterBrain Ischemia, Intracranial Hemorrhages

Start: 2009-06-30End: 2016-12-31Target: 1600Updated: 2015-12-24

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study

Asan Medical CenterBrain Ischemia, Intracranial Hemorrhages

Start: 2009-06-30End: 2016-12-31Target: 800Updated: 2015-12-24

Related Papers

Elevated Pulse Pressure and Recurrent Hemorrhagic Stroke Risk in Stroke With Cerebral Microbleeds or Intracerebral Hemorrhage

Journal of the American Heart Association2021-11-1517 citations

Newly diagnosed diabetes has high risk for cardiovascular outcome in ischemic stroke patients

Scientific Reports2021-06-2110 citations

Cilostazol versus aspirin in ischemic stroke with cerebral microbleeds versus prior intracerebral hemorrhage

International Journal of Stroke2020-07-1419 citations

Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

Journal of Stroke2020-01-315 citations

Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage

Stroke2019-12-2028 citations

Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.

2018-06-0177 citations